Assessment of global functioning in adolescents with autism spectrum disorders: utility of the Developmental Disability-Child Global Assessment Scale.
A single 0-100 clinician rating can track global progress in higher-functioning autistic teens across treatment.
01Research in Context
What this study did
The team tested a short rating scale called the DD-CGAS. It gives one number for overall life skills in teens with autism.
They asked 25 clinicians to score 67 higher-functioning teens. Then they checked if the scores matched core autism signs and IQ.
The teens were in a 12-week social-skills trial, so the team could also see if DD-CGAS picked up real change.
What they found
DD-CGAS scores lined up well with ADOS social scores and with each teen’s verbal IQ.
When teens improved on social and behavior measures, their DD-CGAS number went up too.
A single 0-100 rating tracked treatment gains as well as longer tests, saving time.
How this fits with other research
Tajik-Parvinchi et al. (2023) later showed parents can do the same job. Their ACSF:SC parent ratings also line up with standard measures, but cover instead of just teens.
Spiegel et al. (2023) pushed the DD-CGAS even younger. They linked the same scale to the new ABCS video tool in preschoolers, proving it works across age bands.
Levin et al. (2014) looked at preschoolers and found ADOS, CARS, and SRS often disagree. That clash seems scary, but it’s about different informants. The teen DD-CGAS study avoids that mess by using trained clinicians who see the whole picture.
Why it matters
You now have a one-minute clinician scale that tracks real change in higher-functioning teens. Use it at intake, mid-treatment, and discharge to show parents and funders clear numbers. Pair it with parent tools like ACSF:SC to get both views without extra staff time.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add the 20-item DD-CGAS to your intake packet and re-score every six weeks to graph client progress.
02At a glance
03Original abstract
Assessment of global functioning is an important consideration in treatment outcome research; yet, there is little guidance on its evidence-based assessment for children with autism spectrum disorders. This study investigated the utility and validity of clinician-rated global functioning using the Developmental Disability-Child Global Assessment Scale in a sample of higher functioning adolescents with autism spectrum disorders and comorbid anxiety disorders enrolled in a randomized controlled trial (n = 30). Pretreatment Developmental Disability-Child Global Assessment Scale scores correlated with severity of autism spectrum disorders core symptoms (r = -.388, p = .034), pragmatic communication (r = .407, p = .032), and verbal ability (r = .449, p = .013) and did not correlate with severity of anxiety symptoms or with parent-reported adaptive behavior. Change in Developmental Disability-Child Global Assessment Scale scores during treatment was associated with autism spectrum disorders symptomatic improvement (r = .414, p = .040) and with improved general communication (r = .499, p = .013). Results support the importance of assessing global functioning in addition to symptom change and treatment response in clinical trials.
Autism : the international journal of research and practice, 2014 · doi:10.1177/1362361313481287